filmov
tv
Navigating the Hallucinations and Delusion of Dementia with Dr Erin Foff and Chris Schwilk
Показать описание
Watch the full interview on Being Patient:
Being Patient spoke with Executive Director of ACADIA Pharmaceuticals Dr. Erin Foff and Chris Schwilk, who lives with Lewy body dementia, about managing the hallucinations and delusions of dementia.
- There are currently no FDA-approved drugs for the hallucinations and delusions related to dementia.
- Pimavanserin, a drug developed by ACADIA Pharmaceuticals, is now under FDA review. If approved, it would be the first and only treatment for symptoms of dementia-related psychosis.
- Subtle symptoms of hallucinations or delusions can be easy to miss.
- Caregivers and patients should discuss with their doctors about potential signs of hallucinations or delusions.
Being Patient is piloting an instant messaging online #support #network. These are small intimate groups of people to share insights and learn from others. If you have been diagnosed with #dementia or are caring for a loved one, please sign up here to join:
🗣 𝐒𝐢𝐠𝐧 𝐮𝐩 𝐭𝐨 𝐁𝐞𝐢𝐧𝐠 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐋𝐢𝐯𝐞 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 𝐂𝐡𝐚𝐭 𝐧𝐨𝐰: 🔗
--------------------------------------------------------------------------------------------------------------
We rely on donations to bring you the latest research on dementia and brain health and to support our amazing team of independent journalists. Please consider donating to support of our mission of giving people impacted by dementia a better resource and connection to experts at the forefront of research. Our audience has grown so rapidly; we have exciting plans for the future to enhance our coverage even further but we need your help. Please consider making a contribution to help fund Being Patient's editorial costs.
---------------------------------------------------------------------------------------------------------------
Stay connected on social media:
To catch our Brain Talks live, join our Facebook page:
To learn more about us, follow us on Instagram:
@beingpatientvoices
For the latest news on dementia research and lifestyle tips, visit our site:
Being Patient spoke with Executive Director of ACADIA Pharmaceuticals Dr. Erin Foff and Chris Schwilk, who lives with Lewy body dementia, about managing the hallucinations and delusions of dementia.
- There are currently no FDA-approved drugs for the hallucinations and delusions related to dementia.
- Pimavanserin, a drug developed by ACADIA Pharmaceuticals, is now under FDA review. If approved, it would be the first and only treatment for symptoms of dementia-related psychosis.
- Subtle symptoms of hallucinations or delusions can be easy to miss.
- Caregivers and patients should discuss with their doctors about potential signs of hallucinations or delusions.
Being Patient is piloting an instant messaging online #support #network. These are small intimate groups of people to share insights and learn from others. If you have been diagnosed with #dementia or are caring for a loved one, please sign up here to join:
🗣 𝐒𝐢𝐠𝐧 𝐮𝐩 𝐭𝐨 𝐁𝐞𝐢𝐧𝐠 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐋𝐢𝐯𝐞 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 𝐂𝐡𝐚𝐭 𝐧𝐨𝐰: 🔗
--------------------------------------------------------------------------------------------------------------
We rely on donations to bring you the latest research on dementia and brain health and to support our amazing team of independent journalists. Please consider donating to support of our mission of giving people impacted by dementia a better resource and connection to experts at the forefront of research. Our audience has grown so rapidly; we have exciting plans for the future to enhance our coverage even further but we need your help. Please consider making a contribution to help fund Being Patient's editorial costs.
---------------------------------------------------------------------------------------------------------------
Stay connected on social media:
To catch our Brain Talks live, join our Facebook page:
To learn more about us, follow us on Instagram:
@beingpatientvoices
For the latest news on dementia research and lifestyle tips, visit our site: